CRBP - Company ID 0001595097
Corbus Pharmaceuticals Holdings, Inc. trades as CRBP. This page tracks Corbus Pharmaceuticals Holdings, Inc. through 781 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Net profit margin compressed from -1046.3% to -5176.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-26 |
| Insider trade | 4 | 2026-05-22 |
| New insider ownership | 3 | 2026-05-22 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing Corbus Pharmaceuticals Holdings, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Corbus Pharmaceuticals Holdings, Inc. reported a net loss of $78.54M.